Wednesday, 16 November 2022

Commonly used Inotropic & Vasopressor Agents

Commonly used Inotropic & Vasopressor Agents: 

Ref. Braunwald Heart disease 12th Ed.


DRUG         CLINICAL INDICATION           
   DOSE
                                                                            
CATECHOLAMINES:                                                                               


Dopamine*                 Shock (vasodilatory, cardiogenic) 
    

2 - 20  μg /kg/min (Max-50)
Dobutamine* Low CO (decompensated HF,
cardiogenic shock,
sepsis induced cardiac dysfunction)

2 - 20  μg /kg/min (Max-40)
Norepinephrine
Shock (vasodilatory, cardiogenic)

0.01 - 3  μg /kg/min
Epinephrine Cardiac arrest
Anaphylaxis
Shock (vasodilatory, cardiogenic)

Infusion: 0.01 - 0.10  μg /kg/min
Bolus: 1 mg IV q 3-5 mins (max 0.2 mg/kg)
IM: [1:1000] 0.1 -0.5 mg (max 1 mg)
Isoproterenol Bradyarrhythmias
Brugada syndrome

Infusion: 2 - 10 μg /min
Phenylephrine Hypotension (vagal shock,
medication induced,
Aortic stenosis, HOCM)
Bolus: 0.1 - 0.5 mg IV q 10 to 15 mins
Infusion: 0.4 - 10 μg /kg/min
OTHER AGENTS:

Vasopressin Shock (vasodilatory, cardiogenic)
Cardiac arrest

Bolus: 40 U IV bolus
Infusion: 0.01 - 0.1 U/min
(Common fixed dose 0.04 u/min)
Levosimendan Decompensated HF Loading dose: 12 - 24  μg /kg over 10 mins
Infusion: 0.05 - 0.2 
 μg /kg/min
Phosphodiesterase    
inhibitors:
                        


Milrinone Low CO (decompensated HF,
after cardiotomy)
Infusion: 0.375 - 0.75 μg /kg/min 
(Dose adjustment needed for renal failure)


* For symptomatic bradycardia unresponsive to atropine or pacing - Use dopamine / dobutamine